ethosuximide (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the ethosuximide drug offered from Zydus Pharmaceuticals (USA) Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
| NON-PROPRIETARY NAME: | ethosuximide |
| SUBSTANCE NAME: | ETHOSUXIMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-10-10 |
| END MARKETING DATE: | 0000-00-00 |
ethosuximide HUMAN PRESCRIPTION DRUG Details:
| Item Description | ethosuximide from Zydus Pharmaceuticals (USA) Inc. |
| LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(1-Jan) |
| START MARKETING DATE: | 2012-10-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68382-443_f4d37571-27b3-4d2b-a211-c21491d75718 |
| PRODUCT NDC: | 68382-443 |
| APPLICATION NUMBER: | ANDA200892 |
Other ETHOSUXIMIDE Pharmaceutical Manufacturers / Labelers:
